TILE, EAT, and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 14, 2024. Jean-Jacques Guiony ...
SYRS stock plummets as late-stage cancer study of lead candidate fails to achieve its primary endpoint leading to the termination of the study.
FAF gains from new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback